312-616-5600 (phone)
312-616-5700 (fax)
Chicago Office
Email Attorney
Download V-Card
Related Practices
Education
University of Wisconsin, M.S. in Genetics, 2000
University of Kansas, B.S. in Biology, 1997
Melissa E. Kolom
Technical Advisor
Ms. Kolom's intellectual property practice involves the areas of biotechnology, pharmaceuticals, and chemistry. Recent technologies with which she has been involved include genetic vectors, nucleic acid sequences, proteins, antibody-drug conjugates, monoclonal antibodies, cell lines, immunotherapy, medical treatments, pharmaceutical compositions, generic drug products, and chemical syntheses.
Ms. Kolom has extensive experience in preparing and prosecuting patent applications in the U.S. and foreign countries, and in managing patent portfolios. She also has experience in rendering opinions on patent validity, patent infringement, and has been involved in interference and opposition proceedings.
Professional Affiliations
- Intellectual Property Owners Association (IPO)
Articles and Publications
- "Heterozygosity for a mutation in Brca1 or Atm does not increase susceptibility to ENU-induced mammary tumors in Apc(Min)/+ mice," Kolom (Karabinis) et al., Carcinogenesis, 22(2): 343-6 (2001).
Representative Matters
- Interference No. 104,756 (represented GenVec against Sumitomo Pharmaceuticals in patent interference pertaining to adenoviral vectors, complementary cell lines, and related technology)
- Interference No. 104,822 (represented GenVec against Transgene in patent interference pertaining to adenoviral vectors, complementary cell lines, and related technology)
- Interference No. 104,825 (represented GenVec against Cell Genesys in patent interference pertaining to adenoviral vectors, complementary cell lines, and related technology)
- Interference No. 104,827 (represented GenVec against the University of Texas in patent interference pertaining to adenoviral vectors, complementary cell lines, and related technology)
- Interference No. 104,829 (represented GenVec against Gencell in patent interference pertaining to adenoviral vectors, complementary cell lines, and related technology)
Bar Admissions and Registrations
- Registered to practice before the U.S. Patent and Trademark Office, 2002
